1369. Cefazolin Should Be the First Line for MSSA
Session: Symposium: Mano-a-Mano Controversies in Pediatric ID
Saturday, October 10, 2015: 11:15 AM
Room: 6--CF
Jason Newland, MD, MEd, FPIDS, Children's Mercy Hospital and Clinics, Kansas City, MO



J. Newland, Pfizer/Joint Commission: Grant Investigator , Research grant
RPSdiagnostics: Consultant , Consulting fee

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.